Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Common Equity (2020 - 2025)

Historic Common Equity for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to -$3.1 million.

  • Bio Essence's Common Equity fell 545.48% to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 545.48%. This contributed to the annual value of -$3.0 million for FY2024, which is 7882.92% down from last year.
  • As of Q3 2025, Bio Essence's Common Equity stood at -$3.1 million, which was down 545.48% from -$3.1 million recorded in Q2 2025.
  • Bio Essence's 5-year Common Equity high stood at -$1.2 million for Q2 2023, and its period low was -$3.4 million during Q1 2023.
  • In the last 5 years, Bio Essence's Common Equity had a median value of -$2.7 million in 2022 and averaged -$2.5 million.
  • Per our database at Business Quant, Bio Essence's Common Equity skyrocketed by 5924.47% in 2023 and then tumbled by 10800.15% in 2025.
  • Bio Essence's Common Equity (Quarter) stood at -$2.4 million in 2021, then crashed by 33.34% to -$3.2 million in 2022, then soared by 48.73% to -$1.7 million in 2023, then tumbled by 78.83% to -$3.0 million in 2024, then fell by 4.48% to -$3.1 million in 2025.
  • Its last three reported values are -$3.1 million in Q3 2025, -$3.1 million for Q2 2025, and -$3.2 million during Q1 2025.